Financials
- Market Capitalization 537.1 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.12
売上高対価格比率
1.75
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2130 | MAZE Maze Therapeutics, Inc. - Common Stock | 27.70 USD | +2.18% | +4.33% | +11.24% | -38.49% | 1.54 B USD | ||
| 2166 | RAPP Rapport Therapeutics, Inc. - Common Stock | 30.15 USD | -1.63% | -8.41% | -31.94% | +15.12% | 1.45 B USD | ||
| 3016 | EIKN Eikon Therapeutics, Inc. - Common Stock | 7.26 USD | -2.81% | -3.97% | -18.88% | -57.42% | 393.24 M USD | ||
| 3364 | QTTB Q32 Bio Inc. - Common Stock | 8.74 USD | +4.80% | +5.05% | -20.33% | +122.96% | 260.19 M USD |